bts 54 505 has been researched along with fenfluramine in 1 studies
| Studies (bts 54 505) | Trials (bts 54 505) | Recent Studies (post-2010) (bts 54 505) | Studies (fenfluramine) | Trials (fenfluramine) | Recent Studies (post-2010) (fenfluramine) |
|---|---|---|---|---|---|
| 6 | 1 | 0 | 3,112 | 478 | 222 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auerbach, SB; Gundlah, C; Heal, DJ; Martin, KF | 1 |
1 other study(ies) available for bts 54 505 and fenfluramine
| Article | Year |
|---|---|
In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cyclobutanes; Fenfluramine; Fluoxetine; Male; Microdialysis; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |